Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Cutera (CUTR) at Overweight, Company's Comprehensive Portfolio of Innovative Solutions is Underappreciated, Expect Upward Earnings Revisions
-
Ocugen (OCGN) Prices 15.97M Share Offering at $3.35/sh
-
Ocugen, Inc. Announces Pricing of $53.5 Million Public Offering of Common Stock
-
Ocugen (OCGN) Announces Proposed Public Offering of Common Stock
-
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Reiterates Novan (NOVN) at Overweight, Peak Sales of SB206 Underappreciated, Expect Upwards Earnings Revisions
-
High Tide Inc. (HITI:CN) (HITI) PT Lowered to Cdn$7.25 at Cantor Fitzgerald
-
Best Penny Stocks to Watch This Coming Week
-
Form 424B3 Cantor Fitzgerald Income
-
Cantor Fitzgerald Downgrades BioDelivery Sciences International (BDSI) to Neutral on Pending Takeover
-
Aleafia Health Inc (AH:CN) (ALEAF) PT Lowered to Cdn$0.13 at Cantor Fitzgerald
-
Canopy Growth (WEED:CN) (CGC) PT Raised to Cdn$11 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts vTv Therapeutics (VTVT) at Overweight; Sees 800% Upside
-
Cantor Fitzgerald Starts Poseida Therapeutics, Inc (PSTX) at Overweight
-
UPDATE: Cantor Fitzgerald Starts Oramed Pharma (ORMP) at Overweight
-
Cantor Fitzgerald Starts Iris Energy Ltd. (IREN) at Overweight
-
Best Penny Stocks To Buy? 8 Low Float Stocks To Watch Right Now
-
Insmed (INSM) PT Slashed to $53 at Cantor Fitzgerald, Lower Sales Forecast for Arikayce and Increased OpEx Weigh In
-
Cantor Fitzgerald Downgrades Coeur d'Alene Mines (CDE) to Hold, Following Earnings
-
Royal Gold (RGLD) PT Raised to $130 at Cantor Fitzgerald, Following Earnings
-
Johnson & Johnson (JNJ), Cidara Therapeutics (CDTX), Pfizer (PFE), and PDS Biotechnology (PDSB) - Cantor Fitzgerald's Top Flu Vaccine Candidates for 2022
-
Orchid Island Capital Announces February 2022 Monthly Dividend and January 31, 2022 RMBS Portfolio Characteristics
-
Spero Therapeutics (SPRO) Reiterated at Overweight by Cantor Fitzgerald, SPR206 Results Support Further Development, Expect Upward Earnings Revisions and Multiple Expansion
-
Zoetis (ZTS) Shares Pop on Earnings Beat, Analysts Positive
-
Cantor Fitzgerald Reiterates Zoetis (ZTS) at Overweight, Earnings Potential of Underlying Business is Still Underappreciated
-
CF Acquisition Corp. VI and Rumble Announce Filing of a Registration Statement in Connection with their Proposed Business Combination
-
Cantor Fitzgerald Reiterates Overweight Rating on Aytu Biosciences (AYTU), Company's Transformation Remains Underappreciated
-
Form SC 13G/A PHOENIX BIOTECH ACQUISIT Filed by: CANTOR FITZGERALD SECURITIES
-
Wejo Group Limited (WEJO) Enters $100M Stock Purchase Agreement
-
Wejo Group Limited Secures up to $100 Million in Committed Equity Financing
-
Russell Huewe joins Vida Capital as Managing Director, Business Development
-
Russell Huewe joins Vida Capital as Managing Director, Business Development
-
Form SC 13G/A EVe Mobility Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Form SC 13G/A NAVIENT CORP Filed by: Cantor Fitzgerald Europe
-
Form 13F-NT CANTOR FITZGERALD SECURI For: Dec 31
-
Form 13F-NT CANTOR FITZGERALD & CO. For: Dec 31
-
Form 13F-NT Cantor Fitzgerald Europe For: Dec 31
-
Form 13F-HR CANTOR FITZGERALD, L. For: Dec 31
-
UPDATE: Cantor Fitzgerald Upgrades Collegium Pharmaceutical (COLL) to Buy
-
Form 13F-HR/A CANTOR FITZGERALD INVEST For: Dec 31
-
BTIG Adds Bradford Ainslie to Institutional Equities Division
-
Roivant Sciences Reports Financial Results for the Quarter Ended December 31, 2021 and Provides Business Update
-
Roivant Sciences Reports Financial Results for the Quarter Ended December 31, 2021 and Provides Business Update
-
Westwater Resources (WWR) Reports FY 2021 EPS of ($0.49)
-
Westwater Resources, Inc. Announces Year-End 2021 Results, Business Update and Management Succession Changes
-
Inspirato, the Innovative Luxury Travel Subscription Brand, Closes Transaction to Become Publicly Traded
-
Vista Gold Corp. (VGZ:CN) (VGZ) PT Lowered to Cdn$2.25 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Ideanomics (DIEX) at Overweight (correction)
-
Aurora Cannabis Inc. (ACB:CN) (ACB) PT Lowered to Cdn$7.60 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates SCYNEXIS (SCYX) at Overweight, Company Continues to be Undervalued

